Optimizing Choice of Health Insurance For Diabetes (OrCHID)
优化糖尿病健康保险的选择 (OrCHID)
基本信息
- 批准号:10735392
- 负责人:
- 金额:$ 39.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-03 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT ABSTRACT
Diabetes affects 10% of the U.S. population and is responsible for $237 billion in direct medical costs annually.
Primary care and specialist visits, medications and testing supplies, durable medical equipment, lab testing,
and potential emergency and hospital visits can be costly. Patients with diabetes report a high level of financial
burden relative to patients without diabetes, struggling to pay for necessary health care, food, housing, and
retirement. Cost-related non-adherence (delaying filling a prescription or taking less medicine) for patients with
diabetes is high, and subsequently, patients in health insurance plans with poor coverage for needed services
and resources experience adverse outcomes like hyper- or hypoglycemia, acute cerebrovascular disease, and
ischemic heart disease due to delayed or forgone care. Therefore, choosing a health insurance plan that meets
your needs is critical to improve health, especially for patients with low income socioeconomic status.
Unfortunately, many consumers struggle to choose a health plan from among the many offered, focusing on a
single factor like costs, using heuristics to make decisions, falling subject to biases that challenge rational
decision-making theory, and failing to weigh trade-offs between plan features.
We hypothesize that health economic stated preference methods like discrete choice experiments and multi-
criteria decision analyses can be used to elicit health plan preferences and values. These tools specifically ask
patients to weigh trade-offs between multiple plan features and can assess which features influence patient
decisions the most. In this observational natural experiment study, we will use stated preference surveys to
systematically assess patient preferences for health plans that adequately cover diabetes care. We will
leverage our access to health plan and claims data from Harvard Pilgrim Health Care and the Tufts Health
Plan, two New England-based insurers with a combined 2.2 million covered lives. We will analyze the
concordance between patient preferences and their real-world health plan. Finally, we will assess the
relationship between preference-aligned health plan enrollment and adverse diabetes health outcomes, cost-
related treatment non-adherence, receipt of appropriate high-quality diabetes care, health care costs and
utilization, patient financial burden, and plan satisfaction. If preference-aligned health plans are associated with
better health and health care outcomes, future work will develop a decision aid that allows patients to clarify
their values and preferences for health care and choose a plan that will enable them to use preventive care
that reduces adverse health events and lowers their financial burden. If not, future research can use study
results to design a decision aid that directs consumers to plans with features associated with improved health,
health care utilization, health care costs, and consumer satisfaction.
项目摘要
糖尿病影响着 10% 的美国人口,每年造成 2,370 亿美元的直接医疗费用。
初级保健和专科就诊、药物和检测用品、耐用医疗设备、实验室检测、
潜在的紧急情况和医院就诊的费用可能会很高。糖尿病患者的财务状况较高
相对于非糖尿病患者而言,他们的负担较重,难以支付必要的医疗保健、食物、住房和费用
退休。患有以下疾病的患者与费用相关的不依从性(延迟配药或减少服药)
糖尿病发病率很高,因此健康保险计划中的患者无法获得所需服务
和资源经历不良后果,如高血糖或低血糖、急性脑血管疾病和
由于延迟或放弃护理而导致的缺血性心脏病。因此,选择符合条件的健康保险计划
您的需求对于改善健康至关重要,特别是对于低收入社会经济地位的患者。
不幸的是,许多消费者很难从众多提供的健康计划中选择一个,他们关注的是
诸如成本之类的单一因素、使用启发式决策、受到挑战理性的偏见的影响
决策理论,并且未能权衡计划功能之间的权衡。
我们假设健康经济陈述偏好方法,如离散选择实验和多重选择
标准决策分析可用于得出健康计划偏好和价值观。这些工具特别要求
患者可以权衡多个计划功能之间的权衡,并可以评估哪些功能会影响患者
决定最多。在这项观察性自然实验研究中,我们将使用陈述偏好调查来
系统评估患者对充分涵盖糖尿病护理的健康计划的偏好。我们将
利用我们对哈佛朝圣医疗保健和塔夫茨健康中心的健康计划和索赔数据的访问权
Plan 是两家总部位于新英格兰的保险公司,总共承保 220 万人的生命。我们将分析
患者偏好与其实际健康计划之间的一致性。最后,我们将评估
偏好一致的健康计划注册与不良糖尿病健康结果、成本之间的关系
相关治疗不依从、接受适当的高质量糖尿病护理、医疗保健费用和
利用率、患者经济负担和计划满意度。如果符合偏好的健康计划与
更好的健康和医疗保健结果,未来的工作将开发一种决策辅助工具,让患者能够澄清
他们对医疗保健的价值观和偏好,并选择一个使他们能够使用预防性护理的计划
这减少了不良健康事件并减轻了他们的经济负担。如果没有,未来的研究可以使用研究
结果设计了一个决策辅助工具,指导消费者制定具有改善健康相关功能的计划,
医疗保健利用率、医疗保健成本和消费者满意度。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Davene Renee Wright其他文献
Davene Renee Wright的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Davene Renee Wright', 18)}}的其他基金
Parent-Perceived Important Topics for Childhood Obesity (PPITCH)
家长认为的儿童肥胖重要话题 (PPITCH)
- 批准号:
10180049 - 财政年份:2021
- 资助金额:
$ 39.89万 - 项目类别:
Parent-Perceived Important Topics for Childhood Obesity (PPITCH)
家长认为的儿童肥胖重要话题 (PPITCH)
- 批准号:
10438760 - 财政年份:2021
- 资助金额:
$ 39.89万 - 项目类别:
Improving Childhood Obesity-Related Behavior Change through Better Risk Communication
通过更好的风险沟通改善儿童肥胖相关的行为改变
- 批准号:
10005542 - 财政年份:2016
- 资助金额:
$ 39.89万 - 项目类别:
相似国自然基金
基于伴有生存时间离散选择实验的中国癌症人群FACT-8D健康效用积分体系构建及性能评估研究
- 批准号:72274045
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
基于机器学习和常规电子健康数据的抗菌药物合理选择研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
健康中国背景下患者线上就医选择研究:基于大型互联网医疗平台交易数据的分析
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
社交焦虑大学生的学习生产力减损及心理健康服务选择偏好研究
- 批准号:72004104
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
母乳蛋白的核心岩藻糖基化修饰选择性促进新生儿肠道乳酸杆菌优势生长的机制研究
- 批准号:31900920
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bayesian Methods for Optimizing Combination Antiretroviral Therapy for Mentalhealth in People with HIV
优化艾滋病毒感染者心理健康联合抗逆转录病毒治疗的贝叶斯方法
- 批准号:
10642867 - 财政年份:2022
- 资助金额:
$ 39.89万 - 项目类别:
Optimizing HIV adherence by developing a shared decision support tool to facilitate women's choice between oral and LAI ART
通过开发共享决策支持工具来优化艾滋病毒依从性,以促进妇女在口服抗逆转录病毒疗法和 LAI ART 之间进行选择
- 批准号:
10879873 - 财政年份:2021
- 资助金额:
$ 39.89万 - 项目类别:
Optimizing HIV adherence by developing a shared decision support tool to facilitate women's choice between oral and LAI ART
通过开发共享决策支持工具来优化艾滋病毒依从性,以促进妇女在口服抗逆转录病毒疗法和 LAI ART 之间进行选择
- 批准号:
10254918 - 财政年份:2021
- 资助金额:
$ 39.89万 - 项目类别:
Optimizing HIV adherence by developing a shared decision support tool to facilitate women's choice between oral and LAI ART
通过开发共享决策支持工具来优化艾滋病毒依从性,以促进妇女在口服抗逆转录病毒疗法和 LAI ART 之间进行选择
- 批准号:
10368159 - 财政年份:2021
- 资助金额:
$ 39.89万 - 项目类别:
Optimizing treatment for nursing home residents with acute cholecystitis
优化疗养院居民急性胆囊炎的治疗
- 批准号:
9027788 - 财政年份:2014
- 资助金额:
$ 39.89万 - 项目类别: